CEACAM1 and breast carcinoma: Previous studies have shown that CEACAM1 possesses an ISRE in its promoter region and is synergistically induced by TNFα and IFNγ in endothelial cells, colorectal carcinoma cells, cervix carcinoma cells, and breast carcinoma cells (45–48).